Metropolis Healthcare Acquires Kolhapur’s Ambika Pathology Laboratory, Strengthening its Leadership in Western Maharashtra

Metropolis Healthcare Limited, led by Ameera Shah, has completed the acquisition of Dr. R.S. Patil’s Ambika Pathology Laboratory in Kolhapur. The NABL-accredited facility is among the region’s leading diagnostic providers and has been acquired through a Business Transfer Agreement. This is the fourth acquisition by Metropolis in the last 10 months, strengthening its ‘String of Pearls’ strategy and expanding access to advanced diagnostics across India. Ambika Pathology Laboratory has built a strong reputation for quality, accuracy, and patient-centric care, operating a central laboratory supported by 12 patient touchpoints. The acquisition supports Metropolis’ ambition to make high-quality diagnostics accessible to more communities and strengthens its Western Maharashtra cluster.